Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Head and Neck cancer (HNC) - Market Insight, Epidemiology And Market Forecast - 2032
... and neck cancer (HNC) historical and forecasted epidemiology as well as the Head and neck cancer (HNC) cancer market trends in the United States, EU-5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. ... Read More
-
Intratumoral Cancer Therapies - Market Insight, Epidemiology And Market Forecast - 2032
... forecasted epidemiology as well as the Intratumoral cancer therapies trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Intratumoral cancer therapies market report provides emerging drugs, Intratumoral cancer ... Read More
-
Oncolytic Virus Cancer Therapy - Market Insight, Epidemiology and Market Forecast – 2032
... Therapies (OVTs), historical and forecasted epidemiology as well as the Oncolytic Virus Therapies (OVTs) trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Oncolytic Virus Therapies (OVTs) market ... Read More
-
Hematological Cancer (Blood Cancer) Therapeutics- Market Insights, Competitive Landscape and, Market Forecast - 2027
... End-User (Hospital Pharmacies, Retail Pharmacy, And Others) and by geography is expected to grow at a steady CAGR forecast till 2027 owing to the increasing prevalence of blood cancer and increasing prevalence of lifestyle disorders ... Read More
-
mRNA Cancer Therapies Patent Landscape 2022
... such as mRNA technology leaders CureVac, Moderna and BioNTech. These optimizations were achieved by modifying RNA non-coding elements (5′ cap, 5′- and 3′- UTRs, 3′ poly-A tail) and RNA coding region, and through the development ... Read More
-
3D Cell Culture Market By Product (Scaffold Based Platforms, Scaffold Free Platforms, Gels, Bioreactors, Microchips, Services), By Application (Cancer Research, Stem Cell Research, Drug Discovery, Regenerative medicine), By End User (Biotechnology and Pharmaceutical Companies, Contract Research Laboratories, Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Research Laboratories, Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2021-2031 A 3D cell culture is an in-vitro technique wherein the cells can grow in an artificially created environment. These environments closely resemble the architecture ... Read More
-
North America Biosimilars Market Size, Share & Industry Trends Analysis Report By Application (Oncology Diseases, Blood Disorders, Chronic & Autoimmune Diseases and Others), By Type, By Country and Growth Forecast, 2022 - 2028
... America Biosimilars Market would witness market growth of 23.6% CAGR during the forecast period (2022-2028). Biosimilars are rigorously and thoroughly examined by the FDA before approval, and they are just as secure and efficient as ... Read More
-
Europe Biosimilars Market Size, Share & Industry Trends Analysis Report By Application (Oncology Diseases, Blood Disorders, Chronic & Autoimmune Diseases and Others), By Type, By Country and Growth Forecast, 2022 - 2028
... Market would witness market growth of 23.6% CAGR during the forecast period (2022-2028). The prevalence of autoimmune conditions like rheumatoid arthritis & ankylosing spondylitis is rising, fueling the growth of the biosimilars market. For the ... Read More
-
Global Biosimilars Market Size, Share & Industry Trends Analysis Report By Application (Oncology Diseases, Blood Disorders, Chronic & Autoimmune Diseases and Others), By Type, By Regional Outlook and Forecast, 2022 - 2028
... Market size is expected to reach $59 billion by 2028, rising at a market growth of 24.4% CAGR during the forecast period. Biosimilar medicines are biotherapeutic products that are identical to an approved reference product ... Read More
-
Vaccine Adjuvants Market by Product (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial) & Application Category - Global Forecast to 2027
... to reach USD 1.6 Billion by 2027 from USD 1.5 Billion in 2022, at a CAGR of 1.7% during the forecast period. The growth of the market is projected to be driven by factors such ... Read More
-
Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs In Development, 2022, provides an overview of the Head And Neck Cancer (Oncology) pipeline landscape. Head and Neck Cancer is a cancer that arises in the head or neck region (in the nasal cavity, ... Read More
-
Oropharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Oropharyngeal Cancer (Oncology) pipeline landscape. Oropharyngeal cancer is a disease which malignant cells form in the tissue of oropharynx. Oropharynx is a middle part of the throat which includes the ... Read More
-
Fallopian Tube Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Fallopian Tube Cancer (Oncology) pipeline landscape. Fallopian tube cancer is also called tubal cancer. It develops in the fallopian tubes, which serve as a connection between the ovaries ... Read More
-
Basal Cell Carcinoma (Basal Cell Epithelioma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... (Basal Cell Epithelioma) - Drugs In Development, 2022, provides an overview of the Basal Cell Carcinoma (Basal Cell Epithelioma) (Oncology) pipeline landscape. Basal cell carcinoma is a type of skin cancer which begins in the ... Read More
-
Ureter Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Ureter Cancer (Oncology) pipeline landscape. Ureter cancer or ureteral cancer is cancer of the ureter. Symptoms and signs of urethral cancer include bleeding from the urethra or blood in the ... Read More
-
Hairy Cell Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Hairy Cell Leukemia (Oncology) pipeline landscape. Hairy cell leukemia is a rare, slow-growing cancer of the blood in which bone marrow makes too many B cells (lymphocytes), a ... Read More
-
Gastric Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Gastric Cancer (Oncology) pipeline landscape. Gastric cancer, also called stomach cancer, is a malignant tumor arising from the lining of the stomach. Signs and symptoms of gastric cancer include fatigue, ... Read More
-
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Cancer) - Drugs In Development, 2022, provides an overview of the Adrenocortical Carcinoma (Adrenal Cortex Cancer) (Oncology) pipeline landscape. Adrenal cortex cancer (ACC) is a rare disease. It is caused by a cancerous growth in ... Read More
-
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size study, By Drug (Monoclonal Antibodies, Immunomodulators, Cancer Vaccines and Oncolytic Therapies and Others }, Service (Target Identification and Validation, Lead screening and Characterization, Cell based Assays), By Cancer Type ( Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer and Pancreatic Cancer), and Regional Forecasts 2022-2028
... Cancer Type ( Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer and Pancreatic Cancer), and Regional Forecasts 2022-2028 Global Cancer Immunotherapy Drug Discovery Outsourcing Market is valued approximately ... Read More
-
Nuclear Medicine/Radiopharmaceuticals Market Analysis And Forecast To 2031: By Type (Diagnostics, {SPECT, PET}, Therapeutics {Alpha Emitters, Beta Emitters, Brachytherapy}), By Application (Oncology, Cardiology, Neurology, Orthopedics, Thyroid) And Region
... at USD 7.8 billion in 2021 and it is anticipated to grow up to USD 48.8 billion by 2031, at a CAGR of 20.1% during the forecast period. Nuclear medicine is primarily a specialized area ... Read More
-
Head and Neck Cancer Therapeutics: Global Markets
... to help businesses develop growth strategies, assess the market landscape, analyze their positions in the current marketplace, and make informed business decisions regarding head and neck cancer therapeutic drugs. An in-depth analysis of the global ... Read More
-
Glycomic Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Class (Isolated and Synthetic), Structures [Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins & Heparin Based Glycans, Targeting Glycosphingolipids, and Others], Indications (Thrombosis & Chemoprophylaxis, Anaemia, Anti-Adhesive & Anti-Inflammatory, Cataracts, Gaucher’s Disease, MPS-1 & IV, Cancer, Alzheimer’s Disease, Influenza Type A & B, and Others), and Mode of Action [Inhibits Neuraminidase; Inhibits Heparanase and Selectins and Blocks Interactions Between Growth Factors and Heparan Sulfate; Erythropoietin & Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 & 3; Beta & Gamma Interferons; and Others]
... Others], Indications (Thrombosis & Chemoprophylaxis, Anaemia, Anti-Adhesive & Anti-Inflammatory, Cataracts, Gaucher’s Disease, MPS-1 & IV, Cancer, Alzheimer’s Disease, Influenza Type A & B, and Others), and Mode of Action [Inhibits Neuraminidase; Inhibits Heparanase and Selectins ... Read More
-
Medical Tourism Market Size By Application (Cardiovascular Surgery, Cosmetic Surgery {Hair Transplant, Breast Augmentation}, Dental Surgery, Orthopedic Surgery, Bariatric Surgery, Fertility Treatment, Oncology Treatment), Industry Analysis Report, Regional Outlook, Covid-19 Impact Analysis, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030
... Market Share & Forecast, 2022 - 2030 The medical tourism market is set to register significant growth by 2030 owing to growing geriatric population worldwide. In addition, latest advancements in minimally invasive technology are likely ... Read More
-
Global Intraoperative Radiation Therapy Market, By Technology (Intraoperative Brachytherapy, Electron Intraoperative Radiation Therapy And Others); By Product and Service (Products (Applicators & Afterloaders, Treatment Planning Systems) And Services), By Application (Breast Cancer, Brain Tumor, Lung Cancer, Gastrointestinal Cancer, Endometrial & Cervical Cancer And Others), By Region (North America, Europe, The Asia Pacific, Latin America, The Middle East); Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... Cancer, Gastrointestinal Cancer, Endometrial & Cervical Cancer And Others), By Region (North America, Europe, The Asia Pacific, Latin America, The Middle East); Trend Analysis, Competitive Market Share & Forecast, 2018-2028 Global Intraoperative Radiation Therapy Market ... Read More
-
Immunoassay Market by Product (Reagents & Kits, Analyzers), Technology (ELISA, Rapid Test, Western Blotting, ELISPOT), Specimen (Blood, Saliva), Application (Infectious Diseases, Oncology), End User (Hospitals & Clinics) - Global Forecasts to 2027
... market is valued at an estimated USD 40.2 billion in 2022 and is projected to reach USD 49.6 billion by 2027, at a CAGR of 4.3% during the forecast period. Market growth is driven by ... Read More
Research Assistance
